In the study, researchers at Weill Cornell Medicine and their colleagues also identified new potential treatments for COVID-19 patients and described a model for drug screening.
Diversity leaders at Weill Cornell Medicine have launched ambitious community vaccination and education efforts, with the goal of improving uptake and helping those who are reluctant to get the vaccine.
The center’s latest offering is a two-week online course, developed with eCornell, that provides strategies practitioners can use when caring for their patients remotely.
A team led by investigators at Weill Cornell Medicine and NewYork-Presbyterian has used advanced technology and analytics to map the cellular landscape of diseased lung tissue in severe COVID-19 and other infectious lung diseases.
Radiation therapy appears to increase the expression of genes with mutations that induce an immune response to malignant cells, according to preclinical research by Weill Cornell Medicine.
Cornell experts, including Neil A. Lewis Jr. ’13, assistant professor of communication and social behavior, have been part of several efforts to increase access and increase vaccine confidence, particularly in underserved communities.
Weill Cornell Medicine will launch a suite of innovative programs to foster and sustain a more diverse faculty through the support of the Mastercard Impact Fund.
Excess sugar in the blood, the central feature of diabetes, can react with immune proteins to cause myriad changes in the immune system, including inflammatory changes that promote atherosclerosis, according to a new study.
In the next webinar of the College of Arts and Sciences’ yearlong series, “Racism in America,” panelists will focus on the impact of racism on access to health care and health outcomes, March 29 at 7 p.m.
